oxycodone sold various brand names roxicodone oxycontin extended release form semisynthetic opioid used medically treatment moderate severe pain highly commonly abused usually taken mouth available immediaterelease controlledrelease onset pain relief typically begins within fifteen minutes lasts six hours immediaterelease united kingdom available combination products also available paracetamol acetaminophen ibuprofen naloxone naltrexone common side effects include euphoria constipation nausea vomiting loss appetite drowsiness dizziness itching dry mouth side effects may include addiction dependence substance abuse irritability depression mania delirium hallucinations hypoventilation gastroparesis bradycardia allergic codeine may also allergic use oxycodone early pregnancy appears relatively opioid withdrawal may occur rapidly stopped oxycodone acts activating μopioid taken mouth roughly times effect equivalent amount oxycodone originally produced opium poppy opiate alkaloid thebaine first used medically germany world health organizations list essential available generic commonly prescribed medication united states million number abusedeterrent formulations available combination naloxone oxycodone used managing moderate severe acute chronic pain treatments may improve quality life certain types numerous studies completed appropriate use compound improve quality life patients long term chronic pain oxycodone available controlledrelease tablet intended taken every review found controlledrelease oxycodone comparable immediaterelease oxycodone morphine hydromorphone management moderate severe cancer pain fewer side effects morphine author concluded controlledrelease form valid alternative morphine firstline treatment cancer european association palliative care recommended oxycodone mouth secondline alternative morphine mouth cancer children extended release formulation fda approved relief cancer pain trauma pain pain due major surgery already treated opioids tolerate least mg per day oxycodone provides alternative duragesic fentanyl extendedrelease opioid analgesic approved oxycodone extendedrelease form andor combination naloxone sometimes used offlabel treatment severe refractory restless legs oxycodone available variety formulations mouth us oxycodone approved use mouth available tablets oral solutions parenteral formulations oxycodone brand name oxynorm also available parts world however widely used european spain netherlands united kingdom oxycodone approved intravenous iv intramuscular im use first introduced germany world war iv im administrations oxycodone commonly used postoperative pain management central powers common side effects oxycodone include reduced sensitivity pain delayed gastric emptying euphoria anxiolysis feelings relaxation respiratory common side effects oxycodone include constipation nausea vomiting somnolence dizziness itching dry mouth sweating less common side effects experienced less patients include loss appetite nervousness abdominal pain diarrhea urinary retention dyspnea side effects generally become less intense time although issues related constipation likely continue duration chronic use compound associated constipation issues become serious implicated lifethreatening bowel number specific medications including developed address opioid induced constipation oxycodone combination naloxone managedrelease tablets formulated deter abuse reduce opioidinduced risk experiencing severe withdrawal symptoms high patient become physically dependent discontinues oxycodone abruptly medically drug taken regularly extended period withdrawn gradually rather abruptly people regularly use oxycodone recreationally higher prescribed doses even higher risk severe withdrawal symptoms symptoms oxycodone withdrawal opioids may include anxiety panic attack nausea insomnia muscle pain muscle weakness fevers flulike withdrawal symptoms also reported newborns whose mothers either injecting orally taking oxycodone opioids chronic use oxycodone particularly higher doses often cause concurrent hypogonadism low sex hormone high doses overdoses persons tolerant opioids oxycodone cause shallow breathing slowed heart rate coldclammy skin pauses breathing low blood pressure constricted pupils circulatory collapse respiratory arrest leading cause drugrelated deaths however onwards heroin fentanyl become common causes drugrelated oxycodone overdose also described cause spinal cord infarction high doses ischemic damage brain due prolonged hypoxia suppressed oxycodone metabolized enzymes therefore clearance altered inhibitors inducers enzymes increasing decreasing halflife lists inhibitors inducers see respectively natural genetic variation enzymes also influence clearance oxycodone may related wide interindividual variability halflife ritonavir lopinavirritonavir greatly increase plasma concentrations oxycodone healthy human volunteers due inhibition rifampicin greatly reduces plasma concentrations oxycodone due strong induction also case report fosphenytoin inducer dramatically reducing analgesic effects oxycodone chronic pain dosage medication adjustments may necessary oxycodone semisynthetic opioid highly selective full agonist μopioid receptor main biological target endogenous opioid neuropeptide oxycodone low affinity δopioid receptor dor κopioid receptor kor agonist oxycodone binds mor g proteincomplex released inhibits release neurotransmitters cell decreasing amount camp produced closing calcium channels opening potassium opioids like oxycodone thought produce analgesic effects via activation mor midbrain periaqueductal gray pag rostral ventromedial medulla conversely thought produce reward addiction via activation mor mesolimbic reward pathway including ventral tegmental area nucleus accumbens ventral tolerance analgesic rewarding effects opioids complex occurs due receptorlevel tolerance eg mor downregulation cellularlevel tolerance eg camp upregulation systemlevel tolerance eg neural adaptation due induction δfosb taken orally mg immediaterelease oxycodone considered equivalent analgesic effect mg extended release oxycodone considered twice potent oral similarly opioids oxycodone increases prolactin secretion influence testosterone levels unlike morphine oxycodone lacks immunosuppressive activity measured natural killer cell activity interleukin production vitro clinical relevance metabolites oxycodone also found active mor agonists notably much higher affinity well higher efficacy mor oxymorphone possesses higher affinity mor noroxycodone noroxymorphone possess onethird higher affinity mor mor activation less noroxycodone higher noroxymorphone relative noroxycodone noroxymorphone oxymorphone also longer biological halflives however despite greater vitro activity metabolites determined oxycodone responsible analgesic effect following oral intravenous administration oxymorphone plays minor role responsible analgesic effect oxycodone oral intravenous administration although genotype route administration result differential rates oxymorphone formation unchanged parent compound remains major contributor overall analgesic effect contrast oxycodone oxymorphone noroxycodone noroxymorphone also potent mor agonists poorly cross barrier central nervous system reason minimally analgesic group australian researchers proposed based study rats oxycodone acts kors unlike morphine acts upon research group indicated drug appears highaffinity receptor however conclusion disputed primarily basis oxycodone produces effects typical mor research japanese group suggested effect oxycodone mediated different receptors different specifically diabetic mice kor appears involved antinociceptive effects oxycodone nondiabetic mice receptor seems primarily responsible oxycodone administered orally intranasally via intravenous intramuscular subcutaneous injection rectally bioavailability oral administration oxycodone averages within range rectal administration yielding results intranasal varies individuals mean dose conventional immediaterelease oral oxycodone onset action peak plasma levels drug attained within roughly contrast dose oxycontin oral controlledrelease formulation peak plasma levels oxycodone occur three duration instantrelease oxycodone hours although variable depending oxycodone volume distribution blood distributed skeletal muscle liver intestinal tract lungs spleen equilibrium unbound concentration brain threefold higher unbound concentration conventional oral preparations start reduce pain within minutes empty stomach contrast oxycontin starts reduce pain within one metabolism oxycodone humans occurs liver mainly via cytochrome system extensive complex many minor pathways resulting around range dose oxycodone excreted essentially unchanged unconjugated conjugated major metabolites oxycodone noroxycodone noroxymorphone relatively high oxymorphone immediate metabolism oxycodone humans humans ndemethylation oxycodone noroxycodone major metabolic pathway accounting dose oxycodone odemethylation oxycodone oxymorphone oxycodone represent relatively minor metabolic pathways accounting dose oxycodone several immediate metabolites oxycodone subsequently conjugated glucuronic acid excreted metabolized ndemethylation respectively noxidation subsequently glucuronidated oxymorphone also metabolized first pathway three accounts metabolism oxymorphone making main metabolite oxymorphone latter two pathways account less metabolism ndemethylation oxymorphone noroxymorphone glucuronidated oxycodone metabolized cytochrome system liver pharmacokinetics influenced genetic polymorphisms drug interactions concerning system well liver people fast metabolizers oxycodone others slow metabolizers resulting polymorphismdependent alterations relative analgesia higher activity increases effects oxycodone owing increased conversion oxymorphone higher activity opposite effect decreases effects oxycodone owing increased metabolism noroxycodone dose oxycodone must reduced patients reduced liver clearance oxycodone oxycodone metabolites mainly excreted therefore oxycodone accumulates patients kidney oxycodone eliminated urine unchanged oxycodone ndemethylated metabolites noroxycodone noroxymorphone noroxycodols odemethylated metabolites oxymorphone oxymorphols metabolites oxycodone halflife available generic manufacturer oxycontin controlledrelease preparation oxycodone purdue pharma claimed patent application duration action oxycontin hours patients never performed clinical studies oxycontin given frequent intervals separate filing purdue claims controlledrelease oxycodone provides pain relief said patient least hours however investigation los angeles times found drug wears hours early many people inducing symptoms opiate withdrawal intense cravings oxycontin one doctor lawrence robbins told journalists patients would report oxycontin would provide hours relief doctors often would switch patients dosing schedule every eight hours complained duration action oxycontin short taken twice purdue strongly discouraged practice purdues medical director robert reder wrote one doctor oxycontin developed dosingi request use dosing regimen purdue repeatedly released memos sales representatives ordering remind doctors deviate dosing schedule one memo read dosing oxycontin dosing needs nipped bud journalists covered investigation argued purdue pharma insisted duration action nearly patients despite evidence contrary protect reputation oxycontin drug willingness health insurance managed care companies cover oxycontin despite high cost relative generic opiates purdue sales representatives instructed encourage doctors write prescriptions larger doses instead frequent dosing august memo purdue sales representatives tennessee entitled bonus time neighborhood reminded representatives commissions would dramatically increase successful convincing doctors prescribe larger doses los angeles times journalists argue using interviews opioid addiction experts high doses oxycontin spaced hours apart create combination agony opiate withdrawal lower lows schedule reinforcement relieves agony fostering oxycodones chemical name derived codeine chemical structures similar differing also similar hydrocodone differing hydroxyl group terms biosynthesis oxycodone found naturally nectar extracts orchid family epipactis helleborine together along another opioid thodey et al introduces microbial compound manufacturing system compounds including thodey platform produces natural semisynthetic opioids including system uses saccharomyces cerevisiae transgenes papaver somniferum opium poppy pseudomonas putida turn thebaine input opiates oxycodone andor major metabolites may measured blood urine monitor clearance nonmedical use confirm diagnosis poisoning assist medicolegal death investigation many commercial opiate screening tests crossreact appreciably oxycodone metabolites chromatographic techniques easily distinguish oxycodone martin freund jakob edmund speyer university frankfurt germany published first synthesis oxycodone thebaine freund died speyer wrote obituary german chemical speyer born jewish family frankfurt main became victim holocaust died may second day deportations lodz ghetto death noted ghettos first clinical use drug documented year first first introduced us market may early merck introduced combination product containing scopolamine oxycodone ephedrine german initials ingredients see later renamed scophedal scopolamine ephedrine eukodal last manufactured compounded combination essentially oxycodone analogue morphinebased twilight sleep ephedrine added reduce circulatory respiratory drug became known miracle drug continental europe elsewhere wehrmachts choice battlefield analgesic time drug expressly designed provide patent application package insert referred deep analgesia profound intense euphoria well tranquillisation anterograde amnesia useful surgery battlefield wounding cases oxycodone allegedly chosen common opiates product shown produce less sedation equianalgesic doses compared morphine hydromorphone dilaudid hydrocodone operation himmler skophedal also reportedly injected massive overdose prisoners dressed polish army uniforms staged incident september opened second world personal notes adolf hitlers physician theodor morell indicate hitler received repeated injections eukodal oxycodone produced merck scophedal well dolantin pethidine codeine morphine less frequently oxycodone could obtained late january united states controlled substances act csa passed united states congress signed law president richard nixon october passing csa resulted products containing oxycodone classified schedule ii controlled purdue pharma privately held company based stamford connecticut developed prescription painkiller oxycontin approved fda longterm studies assessment addictive david kessler fda commissioner time later said approval oxycontin doubt mistake certainly one worst medical mistakes major upon release oxycontin hailed medical breakthrough longlasting narcotic could help patients moderate severe pain drug became blockbuster reportedly generated billion revenue oxycodone like opioid analgesics tends induce feelings euphoria relaxation reduced anxiety occasional effects make one commonly abused pharmaceutical drugs united abuse oxycodone well related opioids broadly unique united states common drug abuse oxycodone widely recreationally used opioid america united states million people use opioid drugs us department health human services estimates million people us consume oxycodone nonmedical way opioids responsible drug overdose deaths us emergency room visits occurred due episodes involving recreational use oxycodone hydrocodone involved deaths cases due overdoses acetaminophen component resulting fatal liver september fda released new labeling guidelines long acting extended release opioids requiring manufacturers remove moderate pain indication use instead stating drug pain severe enough require daily aroundtheclock long term opioid updated labeling restrict physicians prescribing opioids moderate pain reformulated oxycontin causing recreational users change heroin cheaper easier october new yorker published story mortimer sackler purdue pharma regarding ties production manipulation oxycodone article links raymond arthur sacklers business practices rise direct pharmaceutical marketing eventually rise addiction oxycodone united states article implies sackler family bears responsibility opioid epidemic united new york times ran piece confirming richard sackler son raymond sackler told company officials measure performance rxs strength giving higher measures higher verified documents tied lawsuit filed massachusetts attorney general maura healey claiming purdue pharma members sackler family knew high doses oxycontin long periods would increase risk serious side effects including despite purdue pharmas proposal billion settlement lawsuit attorneys general states including massachusetts rejected settlement offer september nonmedical use oxycodone existed early national sample injecting drug users australia reported using oxycodone injected last six opioidrelated deaths ontario increased ontario deaths oxycodone overdoses cocaine deaths opioid pain relievers increased deaths per million residents deaths per million residents nonmedical use oxycodone canada became problem areas oxycodone problematic atlantic canada ontario nonmedical use prevalent rural towns many smaller mediumsized oxycodone also widely available across western canada methamphetamine heroin serious problems larger cities oxycodone common rural towns oxycodone diverted doctor shopping prescription forgery pharmacy theft recent formulations oxycodone particularly purdue pharmas crush chew injection dissolveresistant replaced banned oxycontin product canada early led decline recreational use opiate increased recreational use potent drug according canadian centre substance abuse study quoted macleans magazine least fentanylrelated deaths canada fiveyear alberta blood tribe police claimed fall january oxycodone pills lethal fake variation referred oxy containing fentanyl made illegal labs members organized crime responsible ten deaths blood reserve located southwest lethbridge provincewide approximately albertans died fentanylrelated overdoses prescriptions oxycodone rose scotland prompting fears usage problems would mirror united first known death due overdose uk occurred august purdue pharma reformulated longacting oxycodone line marketed oxycontin using polymer make pills difficult crush dissolve reduce nonmedical use fda approved relabeling reformulated version abuseresistant april pfizer manufactures preparation shortacting oxycodone marketed oxecta contains inactive ingredients referred tamperresistant aversion approved fda us june new formulation able deter oral recreational use makes crushing chewing snorting injecting opioid impractical change chemical oxycodone subject international conventions narcotic drugs addition oxycodone subject national laws differ country convention limiting manufacture regulating distribution narcotic drugs league nations included single convention narcotic drugs united nations replaced convention categorized oxycodone schedule global restrictions schedule drugs include limiting exclusively medical scientific purposes production manufacture export import distribution trade use possession drugs requiring medical prescriptions supply dispensation drugs individuals preventing accumulation quantities drugs excess required normal conduct oxycodone schedule derived single convention narcotic drugs commonwealths narcotic drugs act addition schedule australian standard uniform scheduling drugs poisons poisons standard meaning controlled drug available use requires restriction manufacture supply distribution possession use reduce abuse misuse physical psychological oxycodone controlled substance schedule controlled drugs substances act february ontario passed legislation allow expansion already existing drugtracking system publicly funded drugs include privately insured database function identify monitor patients attempts seek prescriptions multiple doctors retrieve multiple pharmacies provinces proposed similar legislation nova scotia legislation already effect monitoring prescription drug use changes coincided changes ontarios legislation target misuse painkillers high addiction rates drugs oxycodone february ontario passed legislation delisting oxycodone provinces public drug benefit program first province delist drug based addictive properties new law prohibits prescriptions oxyneo except certain patients exceptional access program including palliative care extenuating circumstances patients already prescribed oxycodone receive coverage additional year oxyneo disallowed unless designated exceptional access much legislative activity stemmed purdue pharmas decision begin modification oxycontins composition make difficult crush snorting injecting new formulation oxyneo intended preventive regard retain effectiveness painkiller since introducing narcotics safety awareness act ontario committed focusing drug addiction particularly monitoring identification problem opioid prescriptions well education patients doctors act introduced commits establishment unified database fulfil public medical community received legislation positively though concerns ramifications legal changes expressed laws largely provincially regulated many speculate national strategy needed prevent smuggling across provincial borders jurisdictions looser purdue pharmas abuseresistant oxyneo six generic versions oxycontin canadawide approved list prescriptions since june federal minister health rona ambrose announced within three years oxycodone products sold canada would need tamperresistant experts warned generic product manufacturers may technology achieve goal possibly giving purdue pharma monopoly several classaction suits across canada launched purdue group companies affiliates claimants argue pharmaceutical manufacturers meet standard care negligent lawsuits reference earlier judgments united states held purdue liable wrongful marketing practices misbranding since purdue companies paid million settling litigation facing criminal fines drug appendix iii narcotics act betäubungsmittelgesetz law allows physicians dentists veterinarians prescribe oxycodone federal government regulate prescriptions eg requiring oxycodone regulated part schedule hong kongs chapter dangerous drugs oxycodone restricted drug japan import export strictly restricted specially designated organizations prior permit import highprofile case american top toyota executive living tokyo claimed unaware law arrested importing oxycodone oxycodone listed class drug misuse drugs act singapore means offences concerning drug attract severe level punishment conviction unauthorized manufacture drug attracts minimum sentence years imprisonment corporal punishment strokes cane maximum sentence life imprisonment years imprisonment strokes minimum maximum penalties unauthorized trafficking drug respectively years imprisonment strokes cane years imprisonment strokes oxycodone class drug misuse drugs act class drugs considered likely cause harm possession without prescription punishable seven years prison unlimited fine dealing drug illegally punishable life imprisonment unlimited fine oxycodone schedule drug per misuse drugs regulations provide certain exemptions provisions misuse drugs act controlled substances act oxycodone schedule ii controlled substance whether part multiingredient dea lists oxycodone sale use manufacturing opioids acscn approved following annual aggregate manufacturing quotas metric tons sale metric tons conversion unchanged previous oxycodone possession decriminalized us state international narcotics control board estimated short tons oxycodone manufactured worldwide figure grown short tons united states accounted consumption short tons canada germany australia france combined accounted consumption short tons oxycodone illegally manufactured using fake pill imprint accounted consumption illicit tablets later seized us drug enforcement administration according international narcotics control board also reported short tons manufactured number decreased record high short tons expanded expressions compound oxycodone academic literature include unesco convention translations oxycodone oxycodon dutch oxycodone french oxicodona spanish arabic 羟考酮 chinese оксикодон word oxycodone confused oxandrolone oxazepam oxybutynin oxytocin brand names include longtec httpsenwikipediaorgwikioxycodone